| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17K | — |
| R&D Expense | $47K | — |
| SG&A Expense | $1.3M | — |
| Operating Income | -$1.7M | — |
| Interest Expense | $61K | — |
| Pre-tax Income | -$2.8M | — |
| Net Income | -$2.8M | -42.9% |
| EPS (Basic) | -$0.04 | — |
| EPS (Diluted) | -$0.04 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8K | -97.5% |
| Accounts Receivable | $12K | +0.0% |
| Current Assets | $8K | -98.3% |
| Total Assets | $1.7M | -19.4% |
| Current Liabilities | $622K | +55.2% |
| Total Liabilities | $622K | +55.2% |
| Stockholders' Equity | $1.1M | -36.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | — |
| Investing Cash Flow | -$348K | — |
| Financing Cash Flow | $2.2M | — |